Aspergillus Biofilms in Human Disease
- 7 June 2016
- book chapter
- Published by Springer Nature
- Vol. 931, 1-11
Abstract
The biofilm phenotype of Aspergillus species is an important and accepted clinical entity. While industrially these biofilms have been used extensively in important biofermentations, their role in clinical infection is less well defined. A recent flurry of activity has demonstrated that these interesting filamentous moulds have the capacity to form biofilms both in vitro and in vivo, and through various investigations have shown that these are exquisitely resistant to antifungal therapies through a range of adaptive resistance mechanisms independent of defined genetic changes. This review will explore the clinical importance of these biofilms and provide contemporary information with respect to their clinical management.Keywords
This publication has 105 references indexed in Scilit:
- Interkingdom metabolic transformations captured by microbial imaging mass spectrometryProceedings of the National Academy of Sciences, 2012
- Azole Resistance of Aspergillus fumigatus Biofilms Is Partly Associated with Efflux Pump ActivityAntimicrobial Agents and Chemotherapy, 2011
- Genetic Basis ofCandidaBiofilm Resistance Due to Drug‐Sequestering Matrix GlucanThe Journal of Infectious Diseases, 2010
- Azole Resistance Profile of Amino Acid Changes in Aspergillus fumigatus CYP51A Based on Protein Homology ModelingAntimicrobial Agents and Chemotherapy, 2010
- Aspergillus fumigatusMedA governs adherence, host cell interactions and virulenceCellular Microbiology, 2010
- Emerging Infections in BurnsSurgical Infections, 2009
- Aspergillus fumigatus Forms Biofilms with Reduced Antifungal Drug Susceptibility on Bronchial Epithelial CellsAntimicrobial Agents and Chemotherapy, 2008
- A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patientsProceedings of the National Academy of Sciences, 2008
- A New Aspergillus fumigatus Resistance Mechanism Conferring In Vitro Cross-Resistance to Azole Antifungals Involves a Combination of cyp51A AlterationsAntimicrobial Agents and Chemotherapy, 2007
- Candida albicans Als3p is required for wild-type biofilm formation on silicone elastomer surfacesMicrobiology, 2006